Gene Therapy — Core Principles

Core Principles

Gene therapy is a revolutionary medical approach that aims to treat or prevent diseases by modifying a person's genetic material. It targets the root cause of genetic disorders, certain cancers, and infectious diseases.

The core principle involves introducing a functional gene, inactivating a problematic gene, or adding a new gene to cells. This genetic material is delivered using 'vectors,' most commonly modified viruses like retroviruses, adenoviruses, or adeno-associated viruses, which are engineered to carry the therapeutic gene without causing illness.

Gene therapy can be performed 'ex vivo,' where cells are modified outside the body and then reinfused, or 'in vivo,' where the vector is directly administered to the patient. A classic example is the treatment of severe combined immunodeficiency (SCID) caused by adenosine deaminase (ADA) deficiency, where a functional ADA gene is introduced into lymphocytes.

While somatic cell gene therapy (non-heritable changes) is in clinical use, germline gene therapy (heritable changes) raises significant ethical concerns and is not currently practiced.

Important Differences

vs Somatic Cell Gene Therapy vs. Germline Gene Therapy

Aspect	This Topic	Somatic Cell Gene Therapy vs. Germline Gene Therapy
Target Cells	Somatic Cell Gene Therapy: Non-reproductive cells (e.g., lymphocytes, liver cells, muscle cells)	Germline Gene Therapy: Reproductive cells (sperm, egg) or early embryos
Heritability	Somatic Cell Gene Therapy: Genetic changes are not passed on to offspring (non-heritable)	Germline Gene Therapy: Genetic changes are passed on to all future generations (heritable)
Ethical Acceptance	Somatic Cell Gene Therapy: Generally accepted for therapeutic purposes, with ongoing safety and efficacy reviews.	Germline Gene Therapy: Raises significant ethical, safety, and societal concerns; not currently approved or practiced in humans.
Purpose	Somatic Cell Gene Therapy: To treat an existing disease in the individual patient.	Germline Gene Therapy: To prevent a disease from ever occurring in an individual and their descendants.
Clinical Status	Somatic Cell Gene Therapy: In clinical trials and approved for several conditions (e.g., ADA-SCID, certain retinal dystrophies).	Germline Gene Therapy: Prohibited in most countries for human application due to ethical and safety concerns.

The fundamental distinction between somatic and germline gene therapy lies in the target cells and the heritability of the genetic modifications. Somatic gene therapy targets non-reproductive cells, meaning the changes are confined to the treated individual and are not passed to their offspring. This approach is ethically more accepted and is currently in clinical use for various diseases. In contrast, germline gene therapy targets reproductive cells or embryos, leading to heritable changes that would affect all future generations. This raises profound ethical, safety, and societal concerns, leading to its prohibition in human application globally.